SUBSCRIBE
SUBSCRIBE
News   Policy

AspenBio Pharma, Inc. Says FDA Seeks More Data on Appendicitis Test

August 21, 2009 | 
1 min read
Bookmark and Share

Reuters -- AspenBio Pharma Inc said U.S. health regulators have sought additional information on its experimental blood-based test to diagnose appendicitis.
Regulatory
MORE ON THIS TOPIC
Insights
Australia’s clinical trial advantage gains ground amid U.S. uncertainty
October 26, 2026
 · 
4 min read
 · 
Jennifer C. Smith-Parker
German flags waving in the wind at famous Reichstag building, seat of the German Parliament (Deutscher Bundestag), on a sunny day with blue sky and clouds, central Berlin Mitte district, Germany.
Policy
Roche flags ‘final opportunity’ for Germany to reestablish as a reliable investment location
October 23, 2026
 · 
2 min read
 · 
Nick Paul Taylor
aardvark walking in the desert
FDA
FDA uncages Aardvark’s Prader-Willi study after new data cleared safety concerns
October 23, 2026
 · 
3 min read
 · 
Tristan Manalac
Successful businessman throwing green line graph arrow to hit target on rising banknotes bar graph for financial growth profit and cash flow investment achievement concept
FDA
Biohaven shares pop as FDA accepts resubmission for ataxia drug with adcomm expected
October 22, 2026
 · 
2 min read
 · 
Heather McKenzie